GLENMEDE TRUST CO NA - BOC HONG KONG HLDS-SPONS ADR ownership

BOC HONG KONG HLDS-SPONS ADR's ticker is BHKLY and the CUSIP is 096813209. A total of 10 filers reported holding BOC HONG KONG HLDS-SPONS ADR in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of BOC HONG KONG HLDS-SPONS ADR
ValueSharesWeighting
Q1 2020$2,504,0000.0%36,0700.0%0.01%0.0%
Q4 2019$2,504,000
-31.0%
36,070
-32.6%
0.01%
-35.3%
Q3 2019$3,628,000
+142.5%
53,481
+181.1%
0.02%
+142.9%
Q2 2019$1,496,00019,023
+190130.0%
0.01%
Q1 2019$0100.0%0.00%
Q4 2018$0
-100.0%
10
-100.0%
0.00%
-100.0%
Q3 2018$9,302,000
+1.6%
97,838
+0.6%
0.04%
-9.8%
Q2 2018$9,157,000
-26.6%
97,218
-21.1%
0.04%
-21.2%
Q1 2018$12,476,0000.0%123,1520.0%0.05%0.0%
Q4 2017$12,476,000
+4.6%
123,152
+0.3%
0.05%0.0%
Q3 2017$11,933,000
+17.4%
122,816
-1.3%
0.05%
+6.1%
Q2 2017$10,162,0000.0%124,3940.0%0.05%0.0%
Q1 2017$10,162,000
+11.9%
124,394
-2.0%
0.05%0.0%
Q4 2016$9,083,000
+6.8%
126,903
+0.8%
0.05%
+2.1%
Q3 2016$8,503,000
+22.6%
125,893
+8.6%
0.05%
+14.3%
Q2 2016$6,933,000
+28787.5%
115,947
+27906.5%
0.04%
Q1 2016$24,000
+300.0%
414
+276.4%
0.00%
Q4 2015$6,000
-99.8%
110
-99.8%
0.00%
-100.0%
Q3 2015$2,704,000
+14.7%
46,082
+62.8%
0.02%
+17.6%
Q2 2015$2,358,000
+95.7%
28,309
+67.5%
0.02%
+88.9%
Q1 2015$1,205,000
+126.5%
16,899
+112.2%
0.01%
+125.0%
Q4 2014$532,0007,9630.00%
Other shareholders
BOC HONG KONG HLDS-SPONS ADR shareholders Q1 2018
NameSharesValueWeighting ↓
SCHAFER CULLEN CAPITAL MANAGEMENT INC 158,890$15,333,0000.18%
World Asset Management Inc 21,030$2,047,0000.10%
GLENMEDE TRUST CO NA 123,152$12,476,0000.05%
QUADRANT CAPITAL GROUP LLC 835$72,0000.03%
PARAMETRIC PORTFOLIO ASSOCIATES LLC 235,035$22,681,0000.02%
CENTRAL TRUST Co 460$45,0000.00%
Vigilant Capital Management, LLC 116$11,0000.00%
Private Capital Group, LLC 90$9,0000.00%
First Horizon Advisors, Inc. 94$9,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 40$4,0000.00%
View complete list of BOC HONG KONG HLDS-SPONS ADR shareholders